Nervous System Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: i. Stroke survivors between the ages of 30 and 85 years. ii. Stroke survivors at the sub-acute stage i.e. 2-6 months post stroke. iii. Stroke survivors with Gross Muscle Power (GMP) starting from 3 on Medical Research Council Scale Testing of the affected upper limb. iv. Stroke survivors that have starting upper-limb function of the affected upper extremity with reduced spasticity i.e. stroke survivors between stages II and VI on the Brunnstrom scale of stroke recovery. v. Stroke survivors that have only had one stroke episode.
Exclusion criteria
Exclusion criteria: i. Stroke survivors suffering from failure of critical organs. ii. Stroke survivors that have had more than one stroke episode. iii. Stroke survivors with a grip strength of 20mmHg and below using a modified sphygmomanometer on the affected upper limb. iv. Stroke survivors who suffer from mental illness, claustrophobia, motion sickness, vertigo or dizziness. v. Stroke survivors with visual impairments. vi. Stroke survivors who are photosensitive. vii. Stroke survivors with history of seizures, recent brain surgery or epilepsy. viii. Stroke survivors enrolled in another clinical trial involving physical therapy or an investigational drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl Meyer Assessment of Upper Extremity (FMA-UE);Upper Extremity Functional Index (UEFI);Upper Extremity Functional Index (UEFI) | — |
Secondary
| Measure | Time frame |
|---|---|
| Medical Research Council (MRC) Scale ;Wolf Motor Function Test (WMFT): | — |
Countries
Nigeria
Contacts
Intern